>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • BW -13.3% (also evaluating strategic alternatives for non-strategic assets to increase liquidity), EVCM -13.2%, HIBB -12.5%, ADBE -11% (also authorizes new $25 bln share repurchase program), SMAR -10.1%, ZUMZ -9.4%, SMR -9.1%, PD -8.6%, BLNK -7.6%, ULTA -6.4% (also forming JV with Axo to launch Ulta in Mexico; approves $2 bln for repurchases), MNTK -2%, AFYA -1.4%
Other news:
  • GPMT -3.4% (decreases dividend)
  • PANL -2.4% (files $100 mln mixed shelf securities offering; announces renewal of shelf registration statement)
  • CXM -2.4% (strategic partnership with Tech Mahindra to implement AI-first customer experience platform)
  • CDRE -1.7% (prices primary and secondary offering of common stock)
  • NUVB -1.4% (first patient has been dosed in a Phase 1/2 study of NUV-1511)
  • COCO -1.3% (subsidiary entered into a Manufacturing and Purchasing Agreement with Century Pacific Food)
  • BTAI -1% (Announces European Patent Office's Grant of Patent for Method of Treating Agitation in Dementia Using Sublingual Dexmedetomidine)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • CDLX +47.8%, DESP +11.2%, WW +6.4%, GRPN +4.6%, AGRO +4.1%, GETY +3.9%, PHR +3.8%, BKE +3.6%, WPM +1.9%, RDUS +1.8%
Other news:
  • GERN +80% (resumes trading after being halted on Thurs; FDA Advisory Committee voted in favor of the clinical benefit/risk profile of Imetelstat)
  • MDGL +25.2% (confirms FDA approval of Rezdiffra)
  • ISRG +3.7% (FDA provides 510(k) clearance for da Vinci 5)
  • VOD +3.7% (announces reshaped European footprint €8 bln sale of Vodafone Italy & €4 bln capital return)
  • SOPH +3.3% (SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration)
  • ACIU +3% (files $350 mln mixed shelf securities offering)
  • LAW +2.9% (authorizes new $20 mln share repurchase program)
  • GEO +2.8% (Executive Chairman insider buy disclosure - bought 50000 shares at $12.465 - $12.50 worth approx. $624K)
  • HITI +2.4% (will acquire all IP including trademarks and other assets of the Queen of Bud brand)
  • THR +2.4% (authorized the repurchase of up to $50 million of Thermon's outstanding shares of common stock)
  • SWI +2.1% (declared a special cash dividend on the company's common stock of $1.00/share)
  • TRP +2% (to sell Prince Rupert Gas Transmission entities)
  • AJG +1.7% (may sell up to 3 mln shares in ATM offerings)
  • AQST +1.5% (data from pivotal study for Anaphylm)
  • BGNE +1.3% (FDA approves TEVIMBRA)
  • HRTG +1.1% (files $100 mln mixed shelf securities offering) TRIN +1% (increases dividend)

FT : Infrastructure chief hits out at push for UK pension funds to invest more i

Infrastructure chief hits out at push for UK pension funds to invest more in Britain
John Armitt says pension schemes need to ‘find the best possible opportunity’

The UK government’s top infrastructure adviser has hit out at a drive to push pension schemes to invest more in Britain, saying there is “no reason” funds should have a home bias.

Sir John Armitt, chair of the National Infrastructure Commission, said tens of billions of pounds were needed from the private sector to meet infrastructure needs, including energy upgrades, new hospitals and roads.

But he added that it would not be right for pension funds to simply invest in home markets due to ministerial pressure.

“Government needs to recognise this as an international, globally competitive market,” he told attendees at the Trades Union Congress pension conference in London this week.

“Frankly, there’s no reason why any of the pension funds here should say ‘oh, I’ve got to invest in the UK’. You’re looking after your pensions and trying to find the best possible opportunity for them.”

Armitt’s comments will add to a growing backlash against proposals led by chancellor Jeremy Hunt for pension funds to significantly increase their investments in British business and projects to boost growth.

The government is concerned that pension funds, which have some of the nation’s largest pools of capital, are not putting enough money into home markets and depriving early-stage companies of seed finance.

Armitt is one of the most high-profile individuals to speak out against the proposals which were announced in the spring Budget and require pension funds to report how much they have allocated to the UK.

Pension trustees are concerned that the move could undermine their duty to invest in countries where they will secure the best returns for members.

“I am not sure that it is the role of the government to tell trustees where they place their money,” said Armitt.

He added that the government had to be prepared to “do deals” with private companies and pension funds to unlock capital for infrastructure, including more risk sharing.

The NIC provides ministers with independent advice on meeting long-term infrastructure challenges.

Armitt is also chair of the National Express Group and City and Guilds, deputy chair of the Berkeley Group and a member of the Board of Transport for London.

About half of the government’s current pipeline of infrastructure projects is expected to involve the private sector, the Treasury has said.

However, pension funds and other investors prefer to invest in assets that are already built or come with substantial government guarantees that minimise construction risks.

In his Budget, Hunt confirmed new measures that require local authority pension funds and private sector retirement plans to disclose their UK investments. He warned that he would review what further action should be taken if this did not lead to an increase in allocations.

At the same event, the Pensions and Lifetime Savings Association, which represents the UK’s £1tn pensions sector, said the government should not tell pension funds how to invest. “We must maintain the freedom for trustees to invest in the best interests of their members,” said Nigel Peaple, spokesperson for the PLSA.

>>> Europe : Brokers Upgrades & Downgrades - 15th of March 2024

>>> Up
* Aspocomp Group Raised to Accumulate at Inderes; PT 3.50 euros
* Bankinter Raised to Market Perform at KBW; PT 8.09 euros
* Deliveroo Raised to Buy at HSBC; PT 150 pence
* Derwent London Raised to Buy at Berenberg; PT 2,494 pence
* Encavis Raised to Equal-Weight at Morgan Stanley; PT 17.50 euros
* KBC Raised to Equal-Weight at Barclays; PT 63 euros
* Madrigal Pharma Raised to Neutral at B Riley; PT $270
* Monte Paschi Raised to Outperform at KBW; PT 5.68 euros
* Pandora PT Raised to 900 kroner from 820 kroner at RBC
* Panostaja Raised to Accumulate at Inderes; PT 42 euro cents
* Snowflake Raised to Neutral at Guggenheim
* Unicaja Raised to Market Perform at KBW; PT 1.32 euros

>>> Down
* Believe Cut to Hold at HSBC; PT 15 euros
* CVS Group Cut to Sector Perform at RBC; PT 1,200 pence
* Hensoldt Cut to Neutral at Citi; PT 38.40 euros
* MorphoSys ADRs Cut to Equal-Weight at Wells Fargo; PT $18.25
* Solaria Energia Cut to Hold at SocGen; PT 11 euros

>>> Initiation
* Computacenter Rated New Add at Peel Hunt; PT 3,195 pence
* Credit Agricole Resumed Neutral at Citi; PT 13.85 euros
* Tate & Lyle Rated New Buy at Panmure Gordon; PT 925 pence

>>> Call
* Smurfit Upgraded at Morgan Stanley on WestRock Deal Potential
* Stellantis a New Overweight, Favorite Auto Name at Piper Sandler